false0001571123 0001571123 2020-03-26 2020-03-26


 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
Form 8-K
_________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 26, 2020

_________________________________________________________
Science Applications International Corporation
(Exact name of registrant as specified in its charter)
_________________________________________________________
Delaware
 
001-35832
 
46-1932921
(State or other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
12010 Sunset Hills Road, Reston, VA 20190
(Address of Principal Executive Offices) (Zip Code)
(703) 676-4300
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address if changed since last report.) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.0001 per share
SAIC
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
 
 
 
 








Item 1.01. Entry into a Material Definitive Agreement
On March 17, 2020, Science Applications International Corporation (the "Company") and Engility services, LLC, a wholly-owned subsidiary of the Company ("Engility"), entered into an Amendment No.1 (the "Amendment") to the Master Accounts Receivable Purchase Agreement dated as of January 21, 2020 (the "Existing Purchase Agreement"), among the Company, as a seller and seller representative, Engility, as a seller, and MUFG Bank, Ltd., as purchase (the "Purchaser").
Pursuant to the Amendment, the Purchaser's commitment to purchase eligible receivables of the Company and Engility was increased from $200 million to $300 million. The remaining terms in the Existing Purchase Agreement are unchanged.
The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 10.1 hereto and incorporated by reference in this Current Report on Form 8-K.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The information included in Item 1.01 of this Current Report on Form 8-K is also incorporated by reference into this Item 2.03 of this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
 
 
 
 
Exhibit
Number
  
Description of Exhibit
 
 
  
Amendment No.1 to Master Accounts Receivable Purchase Agreement, dated March 17, 2020, among Science Applications International Corporation, Engility Services, LLC, and MUFG Bank, Ltd. 
 
 
 
101
 
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
 
 
 
104
 
The cover page from this Current Report on Form 8-K, formatted as Inline XBRL





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 26, 2020
Science Applications International Corporation
 
 
 
 
 
 
 
By:
 
/s/ Steven G. Mahon
 
 
Steven G. Mahon
 
 
Executive Vice President, General Counsel and Corporate Secretary



Exhibit 10.1



EXECUTION AGREEMENT
AMENDMENT NO. 1 TO MASTER ACCOUNTS RECEIVABLE PURCHASE AGREEMENT
This AMENDMENT NO. 1 to the MASTER ACCOUNTS RECEIVABLE PURCHASE AGREEMENT (this “Amendment”), dated as of March 17, 2020, is among SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, a Delaware corporation (“SAIC”), as a seller and as seller representative (in such capacity as seller representative, the “Seller Representative”), ENGILITY SERVICES, LLC, a Delaware limited liability company (collectively with SAIC, the “Sellers”), as a seller, and MUFG BANK, LTD., as purchaser (the “Purchaser”).
W I T N E S S E T H:
WHEREAS, the Sellers, the Seller Representative and the Purchaser have heretofore entered into the Master Accounts Receivables Purchase Agreement, dated as of January 21, 2020 (as amended, restated, supplemented, assigned or otherwise modified from time to time, the “Receivables Purchase Agreement”); and
WHEREAS, the parties hereto seek to modify the Receivables Purchase Agreement upon the terms hereof.
NOW, THEREFORE, in exchange for good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged and confirmed), the parties hereto agree as follows:
A G R E E M E N T:
1.Definitions. Unless otherwise defined or provided herein, capitalized terms used herein have the meanings attributed thereto in (or by reference in) the Receivables Purchase Agreement.
2.    Amendment to Schedule D to Receivables Purchase Agreement. The Receivables Purchase Agreement is amended by replacing Schedule D thereto in its entirety with Schedule D hereto.
3.    Conditions to Effectiveness. This Amendment shall be effective upon receipt by the Purchaser of an executed counterpart of this Amendment by each party hereto.
4.    Funding of Refundable Discount Advance Account. On the first Settlement Date occurring after the date hereof, the Sellers shall pay to the Purchaser an amount equal to 1.25% of the increase in the Commitment effected by this Amendment to serve as additional Refundable Discount Advance. For administrative convenience it is agreed and the Sellers hereby instruct the Purchaser to withhold such additional Refundable Discount Advance from the Payment Amount to be paid to the Seller Representative (on behalf of the Sellers) on the first Settlement Date occurring after the date hereof and to transfer such amount to the Refundable Discount Advance Account.
5.    Certain Representations, Warranties and Covenants. Each of the Seller Representative and each Seller hereby represents and warrants to the Purchaser, as of the date hereof, that:
(a)    the representations and warranties made by it in the Receivables Purchase Agreement are true and correct in all material respects (unless such representation or warranty contains a materiality qualification and, in such case, such representation and warranty shall be true and correct as made) as of (i) the date hereof and (ii) immediately after giving effect to this Amendment, in each case to the same extent as though made on and as of the date hereof, except to the extent such representations and warranties specifically relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects (unless such representation or warranty contains a materiality qualification and, in such case, such representation and warranty shall be true and correct as made) on and as of such earlier date;
(b)    such Person has the requisite power and authority to enter into and deliver this Amendment, and it has taken all necessary corporate or other action required to authorize the execution, delivery and performance of this Amendment. This Amendment has been duly executed and delivered by such Person;
(c)    this Amendment constitutes the legal, valid and binding obligations of such Person, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization, moratorium and other Laws of general application affecting the rights and remedies of creditors and general principles of equity, regardless of whether enforcement is sought in proceedings in equity or at law; and




(d)    no Facility Suspension Event has occurred and is continuing, or would occur as a result of this Amendment or the transactions contemplated hereby.
6.    Reference to, and Effect on, the Receivables Purchase Agreement and the Purchase Documents.
(a)    The Receivables Purchase Agreement (except as specifically amended herein) and the other Purchase Documents shall remain in full force and effect and the Receivables Purchase Agreement and such other Purchase Documents are hereby ratified and confirmed in all respects by each of the parties hereto.
(b)    The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of Purchaser, nor constitute a waiver of any provision of, the Receivables Purchase Agreement or any other Purchase Document.
(c)    After this Amendment becomes effective, all references in the Receivables Purchase Agreement or in any other Purchase Document to “the Receivables Purchase Agreement,” “this Agreement,” “hereof,” “herein” or words of similar effect, in each case referring to the Receivables Purchase Agreement, shall be deemed to be references to the Receivables Purchase Agreement as amended by this Amendment.
7.    Further Assurances. Each Seller agrees that from time to time, at its expense, it will promptly execute and deliver all further instruments and documents, and take all further action, that the Purchaser may reasonably request in order to perfect, protect or more fully evidence or implement the transactions contemplated hereby.
8.    Costs and Expenses. The Sellers agree, jointly and severally, to pay on demand all actual costs (including reasonable attorneys’ fees and expenses) and reasonable expenses the Purchaser incurs in connection with the preparation, negotiation, documentation and delivery of this Amendment.
9.    Purchase Document. This Amendment is a Purchase Document.
10.    Successors and Assigns. This Amendment shall be binding on and shall inure to the benefit of each party hereto and its successors and assigns.
11.    Counterparts. This Amendment may be executed in any number of counterparts, and by the different parties thereto on separate counterparts; each such counterpart shall be deemed an original and all of such counterparts taken together shall be deemed to constitute one and the same instrument. A facsimile or electronic copy of an executed counterpart of this Amendment shall be effective as an original for all purposes.
12.    Governing Law. THIS AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE APPLICABLE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF (OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW).
13.    Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment or are given any substantive effect.
14.    Invalidity. If at any time any provision of this Amendment shall be adjudged by any court or other competent tribunal to be illegal, invalid or unenforceable, the validity, legality, and enforceability of the remaining provisions hereof shall not in any way be affected or impaired, and the parties hereto will use their best efforts to revise the invalid provision so as to render it enforceable in accordance with the intention expressed in this Amendment.
[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]



IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized, as of the date first above written.

SELLER REPRESENTATIVE:

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, as Seller Representative


By:    /s/ Charlie A. Mathis
Name:    Charlie A. Mathis
Title:    Chief Financial Officer


SELLERS:

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, as a Seller


By:    /s/ Charlie A. Mathis
Name:    Charlie A. Mathis
Title:    Chief Financial Officer


ENGILITY SERVICES, LLC, as a Seller


By:    /s/ Charlie A. Mathis
Name:    Charlie A. Mathis
Title:
Chief Financial Officer

















PURCHASER:

MUFG BANK, LTD.,
as Purchaser


By:    /s/ Richard Gregory Hurst
Name:    Richard Gregory Hurst
Title:    Managing Director







SCHEDULE D TO
MASTER ACCOUNTS RECEIVABLE PURCHASE AGREEMENT


COMMITMENTS OF THE PURCHASERS


Purchaser
Commitment
MUFG Bank, Ltd.
$300,000,000